Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2011 031 246.4 |
96 | EP file number | EAKZ | 11 76 9393.7 |
86 | WO file number | WAKZ | PCT/US2011/032017 |
97 | EP publication number | EPN | 2558586 |
87 | WO publication number | WPN | 2011130195 |
54 | Designation/title | TI | APTAMERE FÜR ß-NGF UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON DURCH ß-NGF VERMITTELTEN KRANKHEITEN UND LEIDEN |
51 | IPC main class | ICM (ICMV) | C07H 19/073 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07H 19/10 (2006.01), C07H 21/04 (2006.01), C12N 15/115 (2010.01) |
22 | DE application date | DAT | Apr 12, 2011 |
96 | EP application date | EAT | Apr 12, 2011 |
86 | WO application date | WAT | Apr 12, 2011 |
43 | Date of first publication | OT | Oct 20, 2011 |
| Date of publication of grant | PET | Oct 12, 2016 |
71/73 | Applicant/owner | INH | Otsuka Pharmaceutical Co., Ltd., Tokyo, JP; SomaLogic Operating Co., Inc. (nach den Gesetzen des Staates Delaware), Boulder, CO, US |
72 | Inventor | IN | SCHNEIDER, Daniel, J., Arvada, Colorado 80005, US; HISAMINATO, Akihiko, Osaka-shi, Osaka 541-0045, JP; WAUGH, Sheela, Erie, Colorado 80516, US; RESNICOW, Daniel, Somerville, MA 02143-3909, US; NAGABUKURO, Akira, Osaka-shi, Osaka 541-0045, JP; ONO, Toshihide, Osaka-shi, Osaka 541-0045, JP |
74 | Representative | VTR | Mewburn Ellis LLP, 80333 München, DE |
| Address for service | | Mewburn Ellis LLP, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 323145 P Apr 12, 2010
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002558586 Searchable text:
EP000002558586 Original document:
EP000002558586B1 Searchable text:
EP000002558586B1 Original document:
WO002011130195 Searchable text:
WO002011130195 |
43 | Date of first publication | EVT | Oct 20, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Apr 4, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 25, 2024 (Show all update days)(Hide all update days)- Jan 25, 2024; Dec 19, 2023; Jun 9, 2022; Apr 29, 2022; Mar 10, 2022; Mar 20, 2021; Sep 3, 2020; Apr 6, 2020; Aug 17, 2019; Apr 18, 2019; Apr 10, 2018; Oct 12, 2017; Sep 14, 2017; Aug 3, 2017; May 9, 2017; Mar 8, 2017; Jan 10, 2017; Nov 8, 2016; Oct 18, 2016; Oct 13, 2016; Jun 9, 2016
- Historical data not available for this/these date(s)
- Apr 4, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 28, 2022 |
| Issue number | HN | 23 |
| Year | PJ | 2022 |
| Publication date | VT | Jun 9, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Otsuka Pharmaceutical Co., Ltd., Tokyo, JP; SomaLogic Operating Co., Inc. (nach den Gesetzen des Staates Delaware), Boulder, CO, US |
71/73 | Previous applicant/owner | INHF | Otsuka Pharmaceutical Co., Ltd., Tokyo, JP, Somalogic, Inc., Boulder, Col., US |
| Date of update of the procedure | REGT | Jun 9, 2022 |